Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Campus
  • RSV
Campus
  • RSV

Atherothrombosis

Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

Science in Atherothrombosis

Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Learn More
Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

Learn More
Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI
  • Atherothrombosis

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Learn More
Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS
  • Atherothrombosis

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Learn More
In hospital outcomes in young patients with AMI: Results from Gulf Coast
  • Atherothrombosis

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Learn More
Unguided de-escalation from Ticagrelor to Clopidogrel
  • Atherothrombosis

Unguided de-escalation from Ticagrelor to Clopidogrel

Learn More
Adherence and persistence analysis in patients treated with DAPT
  • Atherothrombosis

Adherence and persistence analysis in patients treated with DAPT

Learn More
Potent P2Y12 Inhibitors vs Clopidogrel in elderly ACS patients
  • Atherothrombosis

Potent P2Y12 Inhibitors vs Clopidogrel in elderly ACS patients

Learn More

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources